What changed in NATIONAL HEALTH INVESTORS INC's 10-K — 2024 vs 2025
Paragraph-level year-over-year comparison of NATIONAL HEALTH INVESTORS INC's 2024 and 2025 10-K annual filings, covering the Business, Risk Factors, Legal Proceedings, Cybersecurity, MD&A and Market Risk sections. Every new, removed and edited paragraph is highlighted side-by-side so you can see exactly what management changed in the 2025 report.
Top changes in NATIONAL HEALTH INVESTORS INC's 2025 10-K
597 paragraphs added · 599 removed · 390 edited across 8 sections
- Item 7. Management's Discussion & Analysis+253 / −216 · 130 edited
- Item 1. Business+159 / −181 · 122 edited
- Item 1A. Risk Factors+141 / −157 · 107 edited
- Item 7A. Quantitative and Qualitative Disclosures About Market Risk+14 / −11 · 9 edited
- Item 5. Market for Registrant's Common Equity+11 / −13 · 10 edited
Item 1. Business
Business — how the company describes what it does
122 edited+37 added−59 removed43 unchanged
Item 1. Business
Business — how the company describes what it does
… 138 more changes not shown on this page.
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
107 edited+34 added−50 removed115 unchanged
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
… 111 more changes not shown on this page.
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
9 edited+1 added−2 removed8 unchanged
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
Item 2. Properties
Properties — owned and leased real estate
1 edited+5 added−4 removed0 unchanged
Item 2. Properties
Properties — owned and leased real estate
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
2 edited+1 added−3 removed0 unchanged
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
10 edited+1 added−3 removed0 unchanged
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
130 edited+123 added−86 removed11 unchanged
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
… 259 more changes not shown on this page.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure
9 edited+5 added−2 removed0 unchanged
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure